Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry representatives urge policy reforms, including energy access and ...
Find why your AI pilot stalls before production and what to fix next: data, workflows, governance, adoption, or ROI proof ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results